Techniques: Personalized peptide-Fc fusion proteins targeting idiotype B cell receptors for B cell lymphoma

Drug platforms

TECHNOLOGY: Fusion proteins

A method for generating peptide-Fc fusion proteins targeting idiotype B cell receptors on malignant cells could be used to generate personalized

Read the full 247 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE